Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2019-08-23 2019-08-23
Drug Identification Number 02283190 02283190
Brand name GARDASIL GARDASIL
Common or Proper name Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] - Suspension for Injection Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] - Suspension for Injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Strength(s) 20MCG 40MCG 40MCG 20MCG 20MCG 40MCG 40MCG 20MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 Dose 1 Dose
ATC code J07BM J07BM
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-08-22 2019-08-22
Remaining supply date 2018-12-04 2018-12-04
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments